Novo Nordisk ( NVO 0.22%) and Constellation Brands ( STZ -1.15%) are both dividend-paying members of the S&P 500 index. Their stock prices are down sharply over the past 12 months, but investment bank ...

Founder Terry Smith put this down to underperformance of healthcare company Novo Nordisk in his semi-annual letter to shareholders. He said another Danish medical company, Coloplast, was one of the ...

The lack of details about which countries are involved and which companies will be impacted as a result of the new trade deal ...

Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

The bispecific antibody market is experiencing rapid growth, primarily driven by the increasing prevalence of complex chronic diseases, such as cancer and autoimmune disorders, for which conventional ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that human study GLP-1-H25-5 which ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.

Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...

Investing.com -- Italian authorities appointed a special commissioner on Monday to help Novo Nordisk (NYSE: NVO) deliver its planned €2 billion ($2.34 billion) investment in a factory near Rome.